Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index

Adipocyte

Volumn 3, Issue 3, 2014, Pages 190-196

  Mannerås Holm, Louise ^a   Benrick, Anna ^a   Stener Victorin, Elisabet ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Adiponectin receptor 2 (ADIPOR2); Adipose tissue; Chemokine (C C motif) ligand 2 (CCL2); Gene expression; Heme oxygenase (decycling 1) (HMOX1); Insulin sensitivity; Lipoprotein lipase (LPL); PCOS; Twist related protein 1 (TWIST1)

Indexed keywords

ESTRADIOL; MESSENGER RNA; SEX HORMONE BINDING GLOBULIN;

ADIPONECTIN GENE; ADIPOR2 GENE; ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CCL2 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; GENE; GENE EXPRESSION; GLUCOSE INFUSION; HMOX1 GENE; HUMAN; HUMAN TISSUE; LPL GENE; OVARY POLYCYSTIC DISEASE; SUBCUTANEOUS FAT; TWIST1 GENE;

EID: 84922192341     PISSN: 21623945     EISSN: 2162397X     Source Type: Journal    
DOI: 10.4161/adip.28731     Document Type: Article

References (39)

1. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010; 16:347-63; PMID:20159883; http:// dx.doi.org/10.1093/humupd/dmq001
2. Stener-Victorin E, Holm G, Labrie F, Nilsson L, Janson PO, Ohlsson C. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome? J Clin Endocrinol Metab 2010; 95:810-9; PMID:20016048; http://dx.doi.org/10.1210/ jc.2009-1908
3. Mannerås-Holm L, Baghaei F, Holm G, Janson PO, Ohlsson C, Lönn M, Stener-Victorin E. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2011; 96:1068-76; PMID:21252248; http://dx.doi. org/10.1210/jc.2010-2279
4. Mannerås-Holm L, Leonhardt H, Kullberg J, Jennische E, Odén A, Holm G, Hellström M, Lönn L, Olivecrona G, Stener-Victorin E, et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab 2011; 96:E304-11; PMID:21084397; http://dx.doi. org/10.1210/jc.2010-1290
5. Corbould A. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Panminerva Med 2008; 50:279-94; PMID:19078869
6. Arner P. Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome. Biochimie 2005; 87:39-43; PMID:15733735; http://dx.doi.org/10.1016/j. biochi.2004.11.012
7. Carmina E, Bucchieri S, Mansueto P, Rini G, Ferin M, Lobo RA. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril 2009; 91(Suppl):1332-5; PMID:18455165; http://dx.doi.org/10.1016/j. fertnstert.2008.03.007
8. Carmina E, Chu MC, Moran C, Tortoriello D, Vardhana P, Tena G, Preciado R, Lobo R. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril 2008; 89:642-8; PMID:17562334; http://dx.doi.org/10.1016/j. fertnstert.2007.03.085
9. O'Connor A, Phelan N, Tun TK, Boran G, Gibney J, Roche HM. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. J Clin Endocrinol Metab 2010; 95:1378-85; PMID:20080859; http://dx.doi. org/10.1210/jc.2009-1557
10. Mlinar B, Pfeifer M, Vrtacnik-Bokal E, Jensterle M, Marc J. Decreased lipin 1 beta expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome. Eur J Endocrinol 2008; 159:833-9; PMID:18829900; http://dx.doi. org/10.1530/EJE-08-0387
11. Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 2007; 92:2764-72; PMID:17456573; http://dx.doi. org/10.1210/jc.2007-0091
12. Villa J, Pratley RE. Adipose tissue dysfunction in polycystic ovary syndrome. Curr Diab Rep 2011; 11:179-84; PMID:21424395; http://dx.doi. org/10.1007/s11892-011-0189-8
13. Cortón M, Botella-Carretero JI, Benguría A, Villuendas G, Zaballos A, San Millán JL, Escobar-Morreale HF, Peral B. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92:328-37; PMID:17062763; http://dx.doi. org/10.1210/jc.2006-1665
14. Chazenbalk G, Chen Y-H, Heneidi S, Lee J-M, Pall M, Chen Y-DI, Azziz R. Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome. J Clin Endocrinol Metab 2012; 97:E765-70; PMID:22344199; http://dx.doi. org/10.1210/jc.2011-2377
15. Yildiz BO, Azziz R; Androgen Excess and PCOS Society. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society. Fertil Steril 2010; 94:690-3; PMID:19394000; http://dx.doi.org/10.1016/j. fertnstert.2009.03.058
16. Cortón M, Botella-Carretero JI, López JA, Camafeita E, San Millán JL, Escobar-Morreale HF, Peral B. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using twodimensional difference gel electrophoresis and mass spectrometry. Hum Reprod 2008; 23:651-61; PMID:18156650; http://dx.doi.org/10.1093/ humrep/dem380
17. Pettersson AT, Mejhert N, Jernås M, Carlsson LMS, Dahlman I, Laurencikiene J, Arner P, Rydén M. Twist1 in human white adipose tissue and obesity. J Clin Endocrinol Metab 2011; 96:133-41; PMID:20943789; http://dx.doi.org/10.1210/ jc.2010-0929
18. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752-61; PMID:15599400; http://dx.doi.org/10.1172/JCI21625
19. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 1998; 47:1562-9; PMID:9753293; http://dx.doi.org/10.2337/diabetes.47.10.1562
20. Maddux BA, See W, Lawrence JC Jr., Goldfine AL, Goldfine ID, Evans JL. Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of a-lipoic acid. Diabetes 2001; 50:404-10; PMID:11272154; http:// dx.doi.org/10.2337/diabetes.50.2.404
21. Seow K-M, Lin Y-H, Hwang J-L, Wang P-H, Ho L-T, Lin Y-H, Juan C-C. Expression levels of haem oxygenase-1 in the omental adipose tissue and peripheral blood mononuclear cells of women with polycystic ovary syndrome. Hum Reprod 2011; 26:431-7; PMID:21148661; http://dx.doi.org/10.1093/ humrep/deq351
22. Lehr S, Hartwig S, Lamers D, Famulla S, Müller S, Hanisch FG, Cuvelier C, Ruige J, Eckardt K, Ouwens DM, et al. Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics 2012; 11:010504; PMID:21947364; http://dx.doi.org/10.1074/mcp. M111.010504
23. Bao W, Song F, Li X, Rong S, Yang W, Zhang M, Yao P, Hao L, Yang N, Hu FB, et al. Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS One 2010; 5:e12371; PMID:20811623; http://dx.doi.org/10.1371/journal. pone.0012371
24. Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008; 60:79-127; PMID:18323402; http://dx.doi. org/10.1124/pr.107.07104
25. Ndisang JF. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators Inflamm 2010; 2010:359732; PMID:20508722; http://dx.doi.org/10.1155/2010/359732
26. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab 2004; 89:1869-78; PMID:15070958; http://dx.doi. org/10.1210/jc.2003-031327
27. Blouin K, Nadeau M, Perreault M, Veilleux A, Drolet R, Marceau P, Mailloux J, Luu-The V, Tchernof A. Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin Endocrinol (Oxf) 2010; 72:176-88; PMID:19500113; http://dx.doi. org/10.1111/j.1365-2265.2009.03645.x
28. Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011; 95:1048-58, e1-2; PMID:21168133; http://dx.doi.org/10.1016/j. fertnstert.2010.11.036
29. Lindholm A, Blomquist C, Bixo M, Dahlbom I, Hansson T, Sundström Poromaa I, Burén J. No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls. Hum Reprod 2011; 26:1478-85; PMID:21478181; http:// dx.doi.org/10.1093/humrep/der096
30. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116:1793-801; PMID:16823477; http://dx.doi.org/10.1172/ JCI29069
31. Hauner H. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005; 64:163-9; PMID:15960861; http://dx.doi. org/10.1079/PNS2005428
32. Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a metaanalysis. Hum Reprod Update 2009; 15:297-307; PMID:19261627; http://dx.doi.org/10.1093/ humupd/dmp006
33. Lecke SB, Mattei F, Morsch DM, Spritzer PM. Abdominal subcutaneous fat gene expression and circulating levels of leptin and adiponectin in polycystic ovary syndrome. Fertil Steril 2011; 95:2044-9; PMID:21419406; http://dx.doi.org/10.1016/j. fertnstert.2011.02.041
34. Seow KM, Tsai YL, Juan CC, Lin YH, Hwang JL, Ho LT. Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: a preliminary study. Reprod Biomed Online 2009; 19:577-82; PMID:19909601; http://dx.doi. org/10.1016/j.rbmo.2009.05.003
35. Fog Svendsen P, Christiansen M, Hedley PL, Nilas L, Bonlokke Pedersen S, Madsbad S. Adipose expression of adipocytokines in women with polycystic ovary syndrome. Fertil Steril 2012; 98:235-41
36. Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS. Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome. Diabetologia 2006; 49:2723-8; PMID:17001470; http://dx.doi.org/10.1007/ s00125-006-0419-9
37. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-7; PMID:14688154; http://dx.doi. org/10.1093/humrep/deh098
38. Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 2009; 15:477-88; PMID:19279045; http://dx.doi.org/10.1093/humupd/dmp008
39. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-? ? C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/ meth.2001.1262